![]() ![]() Mail order pharmacies counsel patients and caregivers (sometimes independent of the dispensing process) through telephone or email contact and provide other professional services associated with pharmaceutical care appropriate to the setting. It meets any licensing or certification standards set forth by the jurisdiction where it is located.Ī pharmacy which uses common carriers to deliver the medications to patient or their caregivers. Provider Business Mailing Address Details:Ī facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services.Ī pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. The mailing address for Dillon Pharmacy is Po Box 842772,, Boston, Massachusetts - 02284-2772 (mailing address contact number - 51). The current location address for Dillon Pharmacy is 20300 W Kellogg Dr,, Goddard, Kansas and the contact number is 31 and fax number is. The NPI Number for Dillon Pharmacy is 1700151859. SB-Glim 4 : Each box contains 50 tablets in blister pack.Dillon Pharmacy (KWIK SHOP INC) is a Community/Retail Pharmacy in Goddard, Kansas. SB-Glim 3 : Each box contains 50 tablets in blister pack. SB-Glim 2 : Each box contains 60 tablets in blister pack. SB-Glim 1 : Each box contains 60 tablets in blister pack. Insulin therapy should be considered in this situation. Because the potential for hypoglycemia in nursing infants may exist, Glimepiride should be discontinued in nursing mothers. Nursing mothers: Although it is not known whether Glimepiride is excreted in human milk, other sulfonylureas are excreted in human milk. Patients who are planning a pregnancy should consult their physician, and it is recommended that they change over to insulin for the entire course of pregnancy and lactation. On the basis of results from animal studies, Glimepiride should not be used during pregnancy. There are no adequate and well-controlled studies in pregnant women. Glimepiride must not be used in patients hypersensitive to glimepiride & other sulphonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients. Glimepiride is not suitable for the treatment of insulin dependent (type-1) diabetes mellitus or for the treatment of diabetes with a history of ketoacidosis) nor for the treatment of diabetic precoma or coma. Hypoglycaemia, temporary visual impairment, nausea, vomiting diarrhoea, abdominal pain, urticaria, fall in blood pressure. Any increase can be based on regular blood sugar monitoring, and should be gradual, i.e., at intervals of one to two weeks, and carried out stepwise, as follows: 1mg→2mg→3mg→4mg→6mg.ĭose range in patients with well controlled diabetes: The usual dose range in patients with well controlled diabetes is 1 to 4 mg daily. If necessary, the daily dose can be increased. Initial dose and dose titration: The usual initial dose is 1 mg once daily. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. The dosage of SB-Glim (Glimepiride) must be the lowest which is sufficient to achieve the desired metabolic control. In principle, the dosage of SB-Glim (Glimepiride) is governed by the desired blood sugar level. Combined use of Glimepiride and insulin may increase the potential for hypoglycemia. Glimepiride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycemic agent. Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycemic control. ![]() Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin-dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled by diet and exercise alone. SB-Glim 4 : Each Tablet contains Glimepiride USP 4 mg. SB-Glim 3 : Each Tablet contains Glimepiride USP 3 mg. SB-Glim 2 : Each Tablet contains Glimepiride USP 2 mg. SB-Glim 1 : Each Tablet contains Glimepiride USP 1 mg. Generic Name with Specification: Glimepiride USP ![]()
0 Comments
Leave a Reply. |